Latest Articles
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - India Education Diary
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers India Education Diary
Published: Aug. 25, 2025, 3:28 p.m.
GSK forays into oncology in India bringing precision therapies for gynaecological cancers - BioSpectrum India
GSK forays into oncology in India bringing precision therapies for gynaecological cancers BioSpectrum India
Published: Aug. 25, 2025, 2:19 p.m.
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - APN News
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers APN News
Published: Aug. 25, 2025, 11:04 a.m.
GSK introduces Jemperli and Zejula in India to expand oncology portfolio - Express Pharma
GSK introduces Jemperli and Zejula in India to expand oncology portfolio Express Pharma
Published: Aug. 25, 2025, 11 a.m.
GSK forays into oncology in India with Jemperli and Zejula - Indian Pharma Post
GSK forays into oncology in India with Jemperli and Zejula Indian Pharma Post
Published: Aug. 25, 2025, 10:23 a.m.
GSK enters Indian oncology market with gynaecological cancer drugs - The New Indian Express
GSK enters Indian oncology market with gynaecological cancer drugs The New Indian Express
Published: Aug. 25, 2025, 8:44 a.m.
GSK enters into oncology segment; launches therapies for gynaecological cancers - newsdrum.in
GSK enters into oncology segment; launches therapies for gynaecological cancers newsdrum.in
Published: Aug. 25, 2025, 8 a.m.
Does This Patient Really Need a Gyn Oncology Referral? - Cleveland Clinic
Does This Patient Really Need a Gyn Oncology Referral? Cleveland Clinic
Published: Aug. 19, 2025, 4:55 a.m.
Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight - The Malaysian Reserve
Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight The Malaysian Reserve
Published: Aug. 12, 2025, 10:20 p.m.
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in - GlobeNewswire
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in GlobeNewswire
Published: Aug. 6, 2025, 1:03 p.m.
Link copied to clipboard!